Physician Assistant Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Angela McGee

Physician Assistant Big Lake, MN Physician Assistant

NPI 1336557297 CMS profile 11231643

207 Jefferson Blvd, Big Lake, MN 55309

Open in the dashboard

General payments

$325

17 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Angela McGee of Big Lake, MN is reported in the CMS Open Payments database as having received $325 across 17 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $224 10
2021 General $101 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela McGee
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Angela McGee were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Angela McGee Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $101 $132 $37–$438 $132
2022 $224 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. Abbott Laboratories $84 1 payment
  2. Neurocrine Biosciences, Inc. $55 4 payments
  3. Almatica Pharma LLC $37 2 payments
  4. Teva Pharmaceuticals USA, Inc. $31 2 payments
  5. Saluda Medical Americas, Inc. $30 1 payment
  6. Janssen Pharmaceuticals, Inc $25 2 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $14 1 payment
  8. AbbVie, Inc. $13 1 payment
  9. Axsome Therapeutics, Inc. $13 1 payment
  10. Otsuka America Pharmaceutical, Inc. $12 1 payment
  11. Other $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Food and Beverage $325 17 payments
Products named General payments · program years 2021–2022
  1. PROCLAIM $84 1 payment
  2. INGREZZA $42 3 payments
  3. LOREEV XR $37 2 payments
  4. GRALISE $37 2 payments
  5. AUSTEDO $31 2 payments
  6. Evoke SCS $30 1 payment
  7. SPRAVATO $25 2 payments
  8. INVEGA SUSTENNA $25 2 payments
  9. INVEGA $25 2 payments
  10. INVEGA TRINZA $25 2 payments
  11. Other $111 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 50 drugs

Part D claims

2,616

Median for Physician Assistant: 241

Drug cost

$191,590

Median for Physician Assistant: $4,110

Branded share of claims

18.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 16 $53,589
Abilify Maintena Aripiprazole Brand 12 $35,660
Vraylar Cariprazine Hcl Brand 19 $24,913
Doxepin Hcl Generic 28 $5,794
Aripiprazole Generic 102 $5,320
Trintellix Vortioxetine Hydrobromide Brand 11 $5,015
Clozapine Generic 52 $4,377
Desvenlafaxine Succinate Er Desvenlafaxine Succinate Brand 108 $4,273
Escitalopram Oxalate Generic 95 $4,238
Hydroxyzine Hcl Generic 129 $3,544

The 10 drugs with the highest cost, of 50 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$20,179

Medicare's payments for the services billed

Medicare patients

64

Average age 56

Services billed

307

43 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 66%
High blood pressure 52%
Arthritis 41%
Diabetes 31%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

17 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record